SINGLE DOMAIN VHH ANTIBODIES AGAINST HANTAVIRUS

The present invention provides alpaca derived VHHs, therapeutic agents, compositions and methods for the prevention, amelioration and treatment of Hantavirus infections. The inventors obtained two neutralizing single domain VHH antibodies, VHH1 and VHH2 that specifically recognize hantavirus glycopr...

Full description

Saved in:
Bibliographic Details
Main Authors TISCHLER, Nicole, VALENZUELA-NIETO, Guillermo, JARA, Ronald, MUENA CASTILLO, Nicolás Alvaro, ROJAS-FERNÁNDEZ, Alejandro
Format Patent
LanguageEnglish
French
Published 10.10.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides alpaca derived VHHs, therapeutic agents, compositions and methods for the prevention, amelioration and treatment of Hantavirus infections. The inventors obtained two neutralizing single domain VHH antibodies, VHH1 and VHH2 that specifically recognize hantavirus glycoproteins Gn/Gc presented on Viral-like Particles (VLPs). The invention also provides a method for the detection of Hantavirus in a sample and a method for the neutralization of Hantavirus, with VHH1 and VHH2 where the in vivo neutralization of the virus allows to control the disease in an individual. La présente invention concerne des VHH dérivés d'alpaca, des agents thérapeutiques, des compositions et des procédés pour la prévention, le soulagement et le traitement d'infections par hantavirus. Les inventeurs ont obtenu deux anticorps VHH à domaine unique de neutralisation, VHH1 et VHH2 qui reconnaissent de manière spécifique des glycoprotéines de hantavirus Gn/Gc présentées sur des particules de type viral (VLP). L'invention concerne également un procédé de détection de hantavirus dans un échantillon et un procédé de neutralisation de hantavirus, avec VHH1 et VHH2 où la neutralisation in vivo du virus permet de lutter contre la maladie chez un individu.
AbstractList The present invention provides alpaca derived VHHs, therapeutic agents, compositions and methods for the prevention, amelioration and treatment of Hantavirus infections. The inventors obtained two neutralizing single domain VHH antibodies, VHH1 and VHH2 that specifically recognize hantavirus glycoproteins Gn/Gc presented on Viral-like Particles (VLPs). The invention also provides a method for the detection of Hantavirus in a sample and a method for the neutralization of Hantavirus, with VHH1 and VHH2 where the in vivo neutralization of the virus allows to control the disease in an individual. La présente invention concerne des VHH dérivés d'alpaca, des agents thérapeutiques, des compositions et des procédés pour la prévention, le soulagement et le traitement d'infections par hantavirus. Les inventeurs ont obtenu deux anticorps VHH à domaine unique de neutralisation, VHH1 et VHH2 qui reconnaissent de manière spécifique des glycoprotéines de hantavirus Gn/Gc présentées sur des particules de type viral (VLP). L'invention concerne également un procédé de détection de hantavirus dans un échantillon et un procédé de neutralisation de hantavirus, avec VHH1 et VHH2 où la neutralisation in vivo du virus permet de lutter contre la maladie chez un individu.
Author TISCHLER, Nicole
ROJAS-FERNÁNDEZ, Alejandro
JARA, Ronald
MUENA CASTILLO, Nicolás Alvaro
VALENZUELA-NIETO, Guillermo
Author_xml – fullname: TISCHLER, Nicole
– fullname: VALENZUELA-NIETO, Guillermo
– fullname: JARA, Ronald
– fullname: MUENA CASTILLO, Nicolás Alvaro
– fullname: ROJAS-FERNÁNDEZ, Alejandro
BookMark eNrjYmDJy89L5WTQD_b0c_dxVXDx93X09FMI8_BQcPQL8XTyd_F0DVZwdAcKBocoeADFHMM8g0KDeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRiZGBpbG5uaOhMXGqAJp-KLo
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate ANTICORPS VHH À DOMAINE UNIQUE CONTRE HANTAVIRUS
ExternalDocumentID WO2024209377A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2024209377A13
IEDL.DBID EVB
IngestDate Fri Oct 25 05:39:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2024209377A13
Notes Application Number: WO2024IB53265
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241010&DB=EPODOC&CC=WO&NR=2024209377A1
ParticipantIDs epo_espacenet_WO2024209377A1
PublicationCentury 2000
PublicationDate 20241010
PublicationDateYYYYMMDD 2024-10-10
PublicationDate_xml – month: 10
  year: 2024
  text: 20241010
  day: 10
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies UNIVERSIDAD AUSTRAL DE CHILE
FUNDACIÓN CIENCIA PARA LA VIDA
RelatedCompanies_xml – name: UNIVERSIDAD AUSTRAL DE CHILE
– name: FUNDACIÓN CIENCIA PARA LA VIDA
Score 3.5688276
Snippet The present invention provides alpaca derived VHHs, therapeutic agents, compositions and methods for the prevention, amelioration and treatment of Hantavirus...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Title SINGLE DOMAIN VHH ANTIBODIES AGAINST HANTAVIRUS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241010&DB=EPODOC&locale=&CC=WO&NR=2024209377A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La8MwDBale962bmOPbgQ2cgvNs8kOZaR5NBlrUpo0663YaQKDkZY1Y39_skm3nopPlkDIBkn-bEkGeCIUhykXEsHYJOmGgX7QVC3JtHKZmiXVicFqh8dRP5jpr3Nj3oLPbS0M7xP6w5sjokXlaO8199fr_0ssl-dWbnr0A0mrFz8duGKDjjEcIb4Q3eHAm8Ru7IiOg7hNjKacpyJ6N00bsdIBa7zFOu172ZDVpax3g4p_BocTlFfV59Aqqg6cONu_1zpwPG6evDtwxHM08w0SGzvcXEAvCaPRmye48dgOIyELAsGO0nAYs9OdYI-QmKRCgDQ7C6ez5BIefS91Agl1WPwtefEe7yqsXUG7WlXFNQjPKl3SvJ_LRCN6SRSCNmiVCENkqhlLTbmB7j5Jt_vZd3DKpsw3K3IX2vXXd3GPQbemD3yvfgGSdn_Z
link.rule.ids 230,308,780,885,25564,76547
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QfOBNUeMDtYmmt4aWtiweiOkDaJW2hJbKjeyWkpiYQqTGv-_sBpQT2dtMMpndZB7f7s4MwBNluIiaKxRjk2KYJvpB0uoopJOpjCyYQU1eOxyEbW9ivE7NaQU-t7Uwok_oj2iOiBaVob2Xwl-v_i-xXPG3ct1kH0havvSTritv0DGGI8QXsmt3e6PIjRzZcRC3yeFY8FqI3gmxECsdED5zlydPqc3rUla7QaV_CocjlFeUZ1DJizrUnO3stTocB5sn7zociT-a2RqJGztcn0Mz9sPBsCe5UWD5oZR6nmSFiW9HPLuTrAES40TykGal_ngSX8Bjv5c4noI6zP62PHuPdhXWL6FaLIv8CqTnFpuzrJ2pVKfGgmoUbbCzQBiiMt2c69o1NPZJutnPfoCalwTD2dAP327hhLO4n9bUBlTLr-_8DgNwye7Fuf0CutiCyg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SINGLE+DOMAIN+VHH+ANTIBODIES+AGAINST+HANTAVIRUS&rft.inventor=TISCHLER%2C+Nicole&rft.inventor=VALENZUELA-NIETO%2C+Guillermo&rft.inventor=JARA%2C+Ronald&rft.inventor=MUENA+CASTILLO%2C+Nicol%C3%A1s+Alvaro&rft.inventor=ROJAS-FERN%C3%81NDEZ%2C+Alejandro&rft.date=2024-10-10&rft.externalDBID=A1&rft.externalDocID=WO2024209377A1